PsychRights^®
                   Law Project for
              Psychiatric Rights

"Mood Stabilizers"

PsychRights has not yet been able to compile research on the so-called "mood stabilizers" in any sort of comprehensive fashion.  However, we were able to acquire some research about the dangers of Valproic Acid, which is the chemical name for Depakote and similar brand name drugs.

Valproic Acid (Depakote)

• Depakote ER "Label" (2007)

• Valproic Acid Treatment: "Other Considerations," August 27, 1999, by James W. Hawkins, MD

• Reversible Dementia and Apparent Brain Atrophy During Valproate Therapy, by Oscar Papazian. MD,  Elizabeth Cadiaalcs. MD, Israel Alfonso, MD,  Ricardo Archila, MD, Michael Duchowny, MD, and and Jean Aicardi, MD, FRC, in ·Annals of Neurology Vol 38 No 4: 687-691, October 1995.

• Valproate-induced Encephalopathy: Assessment with MR Imaging and 1H MR Spectroscopy, by Sargon Ziyeh, Thorsten Thiel, Joachim Spreer, Joachim Klisch, and Martin Schumacher, Epilepsia Vol 43, No. 9, 1101-5, 2002.

• Valproic Acid-Induced Hyperammonemic Encephalopathy: MR Appearance, by Mark D. Baganz and Peter E. Dross, American Journal of Neuroradiology, AJNR 15:1779- 1781, Oct 1994 0 195·61 08 /94 /1 509-1779.

• Reversible Pseudoatrophy of the Brain and Mental Deterioration Associated with Valproate Treatment, by Renzo Guerrini, Anna Belmonte, Raffaello Canapicchi, Claudia Casalini, and Emilio Perucca, Epilepsia, 39(1):27-32, 1998.

• Pseudoatrophy of the Brain with Valproic Acid Monotherapy, by Richard S. McLachlan,  Canadian Journal of Neurological Sciences, 1987; 14:294-296.

Last modified 6/8/2007
Copyright © 2007 Law Project for Psychiatric Rights. All Rights Reserved